(Q44828249)

6 December 2017

title

Acute effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on dopamine metabolism in mouse and rat striatum (English)

1 reference

6 December 2017

1 reference

Pileblad E

1

1 reference

6 December 2017

Fornstedt B

series ordinal

2

1 reference

6 December 2017

Clark D

series ordinal

3

1 reference

6 December 2017

Carlsson A

series ordinal

4

1 reference

6 December 2017

publication date

1 October 1985

1 reference

Journal of Pharmacy and Pharmacology

6 December 2017

published in

1 reference

6 December 2017

volume

37

1 reference

6 December 2017

issue

10

1 reference

6 December 2017

page(s)

707-711

1 reference

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1985.TB04947.X

Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1985.TB04947.X

Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1985.TB04947.X

Neurochemical and behavioral effects of systematic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1985.TB04947.X

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1985.TB04947.X

Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1985.TB04947.X

Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1985.TB04947.X

Selective accumulation of MPP+ in the substantia nigra: a key to neurotoxicity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1985.TB04947.X

Uptake of MPP(+) by dopamine neurons explains selectivity of parkinsonism-inducing neurotoxin, MPTP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1985.TB04947.X

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1985.TB04947.X

Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1985.TB04947.X

1-Methyl-4-phenylpyridinium ion (MPP+): Identification of a metabolite of MPTP, a toxin selective to the substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1985.TB04947.X

Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1985.TB04947.X

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine destroys dopamine neurons in explants of rat embryo mesencephalon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1985.TB04947.X

High-affinity binding sites for [3H]MPTP may correspond to monamine oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1985.TB04947.X

10.1111/J.2042-7158.1985.TB04947.X

21 January 2018

Identifiers

DOI

1 reference

6 December 2017

1 reference